FY2027 ICD-10-CM reference
E27.1: Primary adrenocortical insufficiency
By the HCC Buddy Coding Team
The official ICD-10-CM descriptor is Primary adrenocortical insufficiency. The FY2027 annual edition starts October 1, 2026. Check the edition that applies to the encounter or inpatient discharge, including any April update.
Billable code. Verified against the official FY2027 order file.
Oct to Dec 2026, PY2027
CMS-HCC V28
Mapped- HCC 51Addison's and Cushing's Diseases, Acromegaly,...Coefficient 0.51 (CNA, PY2027)
CMS-HCC V24
Not used by CMSESRD
Mapped- HCC 23Other Significant Endocrine and Metabolic Dis...Coefficient 0.036 (Dialysis CE, PY2027)
RxHCC
Mapped- HCC 43Pituitary, Adrenal Gland, and Other Endocrine...Coefficient 0.023 (MA-PD CE non-low aged, PY2027)
PACE (CMS-HCC V22 component)
Mapped- HCC 23Other Significant Endocrine and Metabolic Dis...
PACE ESRD (ESRD V21 component)
Mapped- HCC 23Other Significant Endocrine and Metabolic Dis...
PACE RxHCC (2018/2019 component)
Mapped- HCC 43Pituitary, Adrenal Gland, and Other Endocrine...
Jan to Sep 2027, PY2028
CMS-HCC V28
Not published by CMSCMS-HCC V24
Not published by CMSESRD
Not published by CMSRxHCC
Not published by CMSPACE (CMS-HCC V22 component)
Not published by CMSPACE ESRD (ESRD V21 component)
Not published by CMSPACE RxHCC component
Not published by CMSOct to Dec 2026, BY2026
HHS-HCC
PendingJan to Sep 2027, BY2027
HHS-HCC
Not published by CMSFY2027 Tabular instructions
Instructions below include applicable chapter, section and parent-code notes. Each note identifies where it appears in the official source.
Instructional note
All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.
Source: E00-E89 (chapter, inherited).
Excludes1
transitory endocrine and metabolic disorders specific to newborn (P70-P74)
Source: E00-E89 (chapter, inherited).
Excludes1
galactorrhea (N64.3)
Source: E20-E35 (section, inherited).
Excludes1
gynecomastia (N62)
Source: E20-E35 (section, inherited).
Instructional note
Addison's disease
Source: E27.1 (self, direct).
Instructional note
Autoimmune adrenalitis
Source: E27.1 (self, direct).
Excludes1
Addison only phenotype adrenoleukodystrophy (E71.528)
Source: E27.1 (self, direct).
Excludes1
amyloidosis (E85.-)
Source: E27.1 (self, direct).
Excludes1
tuberculous Addison's disease (A18.7)
Source: E27.1 (self, direct).
Excludes1
Waterhouse-Friderichsen syndrome (A39.1)
Source: E27.1 (self, direct).
Compare the FY2027 additions, removals and billable-status changes
What does E27.1 mean in FY2027?
The official ICD-10-CM descriptor is Primary adrenocortical insufficiency. The FY2027 annual edition starts October 1, 2026. Check the edition that applies to the encounter or inpatient discharge, including any April update.
Is E27.1 billable in FY2027?
The FY2027 order file marks E27.1 as billable. Check the complete Tabular instructions and documentation before assigning it.
Does E27.1 map to an HCC?
Oct to Dec 2026, PY2027: CMS-HCC V28 HCC 51 (Addison's and Cushing's Diseases, Acromegaly, and Other Specified Endocrine Disorders); CMS-HCC V24: Not used by CMS; ESRD HCC 23 (Other Significant Endocrine and Metabolic Disorders); RxHCC HCC 43 (Pituitary, Adrenal Gland, and Other Endocrine and Metabolic Disorders). Jan to Sep 2027, PY2028: CMS-HCC V28: Not published by CMS; CMS-HCC V24: Not published by CMS; ESRD: Not published by CMS; RxHCC: Not published by CMS. Oct to Dec 2026, BY2026: HHS-HCC: Pending. Jan to Sep 2027, BY2027: HHS-HCC: Not published by CMS. Base coefficients are reference values, not a member total.
Source: CMS FY2027 ICD-10-CM order file. Payment model: CMS CY 2027 Rate Announcement. Read the FY2027 Official Guidelines.
Review the FY2026 April edition
